Celltech and RSPPN Introduce Non-Surgical Stem Cell Therapy

Indonesia’s medical field has documented a new historical milestone in regenerative medicine. A strategic collaboration between Celltech Stem Cell Centre (Vinski Tower) and RSPPN Panglima Besar Soedirman Hospital has introduced the latest innovation in precision stem cell therapy based on C-Arm technology.

This cutting-edge method enables patients to obtain maximum cellular regeneration benefits without undergoing open surgical procedures. The therapy is directly handled by world-class stem cell expert Prof. Dr. Deby Vinski, MSc, Ph.D, an Indonesian, working in collaboration with orthopaedic specialist Dr. Sunaryo Kusumo, M.Kes, Sp.OT.

One prominent national figure who has benefited from this technology is Guruh Sukarno Putra. He underwent Knee Rejuvenation procedures as well as a Men Vitality & Wellness programme based on regenerative medicine.

The utilisation of C-Arm fluoroscopy technology enables the procedure to be conducted with minimal invasiveness. This real-time imaging technology provides doctors with the ability to monitor needle movement and stem cell distribution directly on a monitor screen during the procedure.

Deby Vinski emphasised that precision is the key to successful modern regenerative therapy. “Stem cell therapy is not merely an injection, but a precision biological intervention. With C-Arm, we ensure that stem cells truly reach the area requiring regeneration,” stated the expert who also serves as President of the World Council of Stem Cell in Geneva, Switzerland.

The collaboration between Celltech and RSPPN strengthens Indonesia’s position as an emerging leader in the stem cell field across Asia. The integration of biological expertise and modern orthopaedic intervention technology has become a new model for innovation-based healthcare services in the country.

RSPPN, as a national referral hospital, now presents a more modern, precise, and patient-safety oriented medical approach. This initiative pioneered by Deby supports the transformation of the national healthcare system towards world-class precision medicine services.

With the introduction of this technology, Indonesian society now has access to the most advanced regenerative treatment without requiring overseas travel, whilst simultaneously demonstrating that domestic medical innovation can compete on the global stage.